Software as a service platform development
in Westwood

A trial period is a bet made twice. The buyer bets a short amount of time against the cost of a wrong purchase. The vendor bets that the product will prove itself before the bet runs out. Getting the length and the limits of that period right matters more than almost any other early decision in a subscription product. A trial that ends too soon looks untested. One that runs too long looks like a free tier in disguise.

Length should follow the buying decision, not a habit copied from a competitor. A tool a person can evaluate in one sitting needs only a handful of days. A platform that a team has to configure, populate with real data, and test against a real workflow needs closer to a month. Only then can anyone judge it fairly. Setting the trial shorter than the honest evaluation time just pushes the decision past the deadline anyway, usually with an extension request nobody wanted to process.

Whether to ask for a card up front changes who shows up. Skipping the card lowers the barrier to starting a trial. It brings in a wider, more curious group, many of whom were never going to buy. Requiring a card filters harder at the door. It brings in people closer to a real decision, and removes the awkward moment at the end of the trial when billing has to start from nothing. Neither choice is free of a downside. Self-serve products lean toward no card. Anything sold with a demo or a sales conversation can ask for one without losing the lead.

Feature limits during a trial should mirror the real product. They should not shrink it. A trial that hides the feature a buyer most needs to see, in order to save it as a paid upgrade later, tends to produce a trial user who never discovers the reason to pay. A better limit caps volume, seats, or storage rather than function. The person then experiences the actual product and simply outgrows a ceiling, rather than hitting a wall.

Setup work done during a trial has to survive past it. Suppose a trial account loses its configuration, its imported data, or its integrations the moment the trial expires. Converting then means starting over. That is a strong reason to look elsewhere instead. The account, its settings, and everything a person built during the trial should carry forward unchanged into a paid plan, with only the billing state changing underneath it.

The expiration moment itself needs a plan, not a silent cutoff. A trial that simply stops working at midnight, with no warning and no path forward, reads as broken rather than expired. A short warning window before the deadline helps. So does a read-only or reduced-access state after it, rather than a hard lock. Either gives a person time to decide calmly, and gives the vendor a second and third chance to be noticed.

Multi-tenant platforms complicate the moment of conversion. A trial often belongs to one person while the product is meant for a team. Say three colleagues joined during the evaluation, and only one of them holds the billing relationship. The system has to make it clear who is responsible for converting the account, and what happens to the other seats if that person leaves before deciding. Leaving this ambiguous invites a trial that quietly outlives its intended length, because nobody is sure whose job it is to act.

Extensions are sometimes necessary. They should be treated as a deliberate exception. They should not become a default response to every request. A short, one-time extension, granted with a reason attached, keeps the process honest. An unlimited or repeatable extension trains buyers to expect one. It turns the trial period into a suggestion rather than a boundary.

Measuring what happened during a trial matters. It matters more than whether it converted. An account that used the product every day and still did not convert is telling a different story than one that logged in once and vanished. The two deserve different follow-up messages. Sending the same generic reminder to both wastes the signal. Tracking activity through the trial, and connecting it to the outcome afterward, turns the trial period into a feedback loop for the product itself, alongside its role as a sales tool.